Breakthrough in Stem Cell Therapy: Implanting Neurons Derived from Human Embryonic Stem Cells into the Brain

This October, surgeons at Lund University in Sweden implanted neurons derived from human embryonic stem cells (ES) into a patient's brain, with the hope that these cells could eventually replace some of the patient's damaged tissue.

This trial is part of over 100 stem cell clinical trials aimed at exploring the potential of stem cells in treating serious or life-threatening diseases such as cancer, diabetes, epilepsy, heart failure, and eye disorders. Unlike many unapproved therapies that often use stem cells incapable of transforming into new tissue, these trials are focused on using cells with regenerative potential.

Currently, all trials are relatively small in scale and primarily focused on safety assessment. However, there are still numerous challenges in the research, such as selecting cells most suitable for specific purposes and avoiding the use of immunosuppressive drugs. While these drugs can prevent the patient's body from rejecting the transplanted cells, they also increase the risk of infections.

Nevertheless, a series of clinical studies signal significant progress in stem cell therapy. After decades of in-depth research, the safety and potential applications of stem cells in tissue regeneration are gradually being validated, despite the ethical and political controversies that often accompany such research.

Researchers anticipate that some stem cell therapies will soon enter clinical practice. They believe that for the treatment of certain specific diseases, stem cell therapy may become a mainstream medical approach within the next 5 to 10 years.